nodes	percent_of_prediction	percent_of_DWPC	metapath
Indapamide—CA9—gall bladder—pancreatic cancer	0.0114	0.162	CbGeAlD
Indapamide—KCNQ1—islet of Langerhans—pancreatic cancer	0.00777	0.11	CbGeAlD
Indapamide—CA9—islet of Langerhans—pancreatic cancer	0.0075	0.106	CbGeAlD
Indapamide—KCNQ1—pancreas—pancreatic cancer	0.00546	0.0772	CbGeAlD
Indapamide—CA7—digestive system—pancreatic cancer	0.00512	0.0724	CbGeAlD
Indapamide—KCNQ1—digestive system—pancreatic cancer	0.00467	0.0659	CbGeAlD
Indapamide—CA9—digestive system—pancreatic cancer	0.0045	0.0636	CbGeAlD
Indapamide—CA2—gall bladder—pancreatic cancer	0.00434	0.0614	CbGeAlD
Indapamide—CA5B—pancreas—pancreatic cancer	0.0035	0.0494	CbGeAlD
Indapamide—CA4—islet of Langerhans—pancreatic cancer	0.00343	0.0485	CbGeAlD
Indapamide—CA12—digestive system—pancreatic cancer	0.00333	0.047	CbGeAlD
Indapamide—CA2—islet of Langerhans—pancreatic cancer	0.00285	0.0402	CbGeAlD
Indapamide—CA4—digestive system—pancreatic cancer	0.00206	0.0291	CbGeAlD
Indapamide—CA2—pancreas—pancreatic cancer	0.002	0.0283	CbGeAlD
Indapamide—CA2—digestive system—pancreatic cancer	0.00171	0.0241	CbGeAlD
Indapamide—CYP3A4—digestive system—pancreatic cancer	0.0011	0.0156	CbGeAlD
Indapamide—Angina pectoris—Doxorubicin—pancreatic cancer	0.000534	0.000575	CcSEcCtD
Indapamide—Hypersensitivity—Irinotecan—pancreatic cancer	0.000532	0.000573	CcSEcCtD
Indapamide—Pneumonia—Epirubicin—pancreatic cancer	0.000531	0.000572	CcSEcCtD
Indapamide—Drowsiness—Epirubicin—pancreatic cancer	0.000528	0.000569	CcSEcCtD
Indapamide—Bronchitis—Doxorubicin—pancreatic cancer	0.000527	0.000567	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000524	0.000564	CcSEcCtD
Indapamide—Chest pain—Docetaxel—pancreatic cancer	0.000521	0.000561	CcSEcCtD
Indapamide—Arthralgia—Docetaxel—pancreatic cancer	0.000521	0.000561	CcSEcCtD
Indapamide—Myalgia—Docetaxel—pancreatic cancer	0.000521	0.000561	CcSEcCtD
Indapamide—Nausea—Sunitinib—pancreatic cancer	0.000521	0.000561	CcSEcCtD
Indapamide—Renal failure—Epirubicin—pancreatic cancer	0.000519	0.000559	CcSEcCtD
Indapamide—Asthenia—Irinotecan—pancreatic cancer	0.000519	0.000558	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000518	0.000557	CcSEcCtD
Indapamide—Jaundice—Epirubicin—pancreatic cancer	0.000515	0.000554	CcSEcCtD
Indapamide—Stomatitis—Epirubicin—pancreatic cancer	0.000515	0.000554	CcSEcCtD
Indapamide—Conjunctivitis—Epirubicin—pancreatic cancer	0.000514	0.000553	CcSEcCtD
Indapamide—Urinary tract infection—Epirubicin—pancreatic cancer	0.000514	0.000553	CcSEcCtD
Indapamide—Dysuria—Doxorubicin—pancreatic cancer	0.000513	0.000552	CcSEcCtD
Indapamide—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00051	0.000549	CcSEcCtD
Indapamide—Dry mouth—Docetaxel—pancreatic cancer	0.00051	0.000549	CcSEcCtD
Indapamide—Sweating—Epirubicin—pancreatic cancer	0.000507	0.000545	CcSEcCtD
Indapamide—Pollakiuria—Doxorubicin—pancreatic cancer	0.000507	0.000545	CcSEcCtD
Indapamide—Asthenia—Gemcitabine—pancreatic cancer	0.000505	0.000544	CcSEcCtD
Indapamide—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.0005	0.000539	CcSEcCtD
Indapamide—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.0005	0.000538	CcSEcCtD
Indapamide—Anaphylactic shock—Docetaxel—pancreatic cancer	0.0005	0.000538	CcSEcCtD
Indapamide—Oedema—Docetaxel—pancreatic cancer	0.0005	0.000538	CcSEcCtD
Indapamide—Pruritus—Gemcitabine—pancreatic cancer	0.000498	0.000536	CcSEcCtD
Indapamide—Infection—Docetaxel—pancreatic cancer	0.000496	0.000534	CcSEcCtD
Indapamide—Weight decreased—Doxorubicin—pancreatic cancer	0.000496	0.000534	CcSEcCtD
Indapamide—Sinusitis—Epirubicin—pancreatic cancer	0.000496	0.000533	CcSEcCtD
Indapamide—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000495	0.000532	CcSEcCtD
Indapamide—Diarrhoea—Irinotecan—pancreatic cancer	0.000494	0.000532	CcSEcCtD
Indapamide—Agranulocytosis—Epirubicin—pancreatic cancer	0.000493	0.000531	CcSEcCtD
Indapamide—Pneumonia—Doxorubicin—pancreatic cancer	0.000492	0.000529	CcSEcCtD
Indapamide—Shock—Docetaxel—pancreatic cancer	0.000492	0.000529	CcSEcCtD
Indapamide—Nervous system disorder—Docetaxel—pancreatic cancer	0.00049	0.000527	CcSEcCtD
Indapamide—Pruritus—Fluorouracil—pancreatic cancer	0.00049	0.000527	CcSEcCtD
Indapamide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000489	0.000526	CcSEcCtD
Indapamide—Drowsiness—Doxorubicin—pancreatic cancer	0.000489	0.000526	CcSEcCtD
Indapamide—Tachycardia—Docetaxel—pancreatic cancer	0.000488	0.000525	CcSEcCtD
Indapamide—Skin disorder—Docetaxel—pancreatic cancer	0.000485	0.000522	CcSEcCtD
Indapamide—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000485	0.000522	CcSEcCtD
Indapamide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000482	0.000518	CcSEcCtD
Indapamide—Renal failure—Doxorubicin—pancreatic cancer	0.000481	0.000517	CcSEcCtD
Indapamide—Dizziness—Irinotecan—pancreatic cancer	0.000478	0.000514	CcSEcCtD
Indapamide—Stomatitis—Doxorubicin—pancreatic cancer	0.000477	0.000513	CcSEcCtD
Indapamide—Jaundice—Doxorubicin—pancreatic cancer	0.000477	0.000513	CcSEcCtD
Indapamide—Anorexia—Docetaxel—pancreatic cancer	0.000476	0.000512	CcSEcCtD
Indapamide—Rhinitis—Epirubicin—pancreatic cancer	0.000476	0.000512	CcSEcCtD
Indapamide—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000475	0.000511	CcSEcCtD
Indapamide—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000475	0.000511	CcSEcCtD
Indapamide—Hepatitis—Epirubicin—pancreatic cancer	0.000474	0.00051	CcSEcCtD
Indapamide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000474	0.00051	CcSEcCtD
Indapamide—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000472	0.000508	CcSEcCtD
Indapamide—Pharyngitis—Epirubicin—pancreatic cancer	0.000471	0.000507	CcSEcCtD
Indapamide—Sweating—Doxorubicin—pancreatic cancer	0.000469	0.000504	CcSEcCtD
Indapamide—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000468	0.000504	CcSEcCtD
Indapamide—Oedema peripheral—Epirubicin—pancreatic cancer	0.000467	0.000503	CcSEcCtD
Indapamide—Hypotension—Docetaxel—pancreatic cancer	0.000467	0.000502	CcSEcCtD
Indapamide—Urethral disorder—Epirubicin—pancreatic cancer	0.000465	0.0005	CcSEcCtD
Indapamide—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000462	0.000498	CcSEcCtD
Indapamide—Vomiting—Irinotecan—pancreatic cancer	0.00046	0.000495	CcSEcCtD
Indapamide—Sinusitis—Doxorubicin—pancreatic cancer	0.000459	0.000494	CcSEcCtD
Indapamide—Dizziness—Fluorouracil—pancreatic cancer	0.000458	0.000493	CcSEcCtD
Indapamide—Visual impairment—Epirubicin—pancreatic cancer	0.000457	0.000492	CcSEcCtD
Indapamide—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000456	0.000491	CcSEcCtD
Indapamide—Rash—Irinotecan—pancreatic cancer	0.000456	0.00049	CcSEcCtD
Indapamide—Dermatitis—Irinotecan—pancreatic cancer	0.000455	0.00049	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000455	0.00049	CcSEcCtD
Indapamide—Headache—Irinotecan—pancreatic cancer	0.000453	0.000487	CcSEcCtD
Indapamide—Insomnia—Docetaxel—pancreatic cancer	0.000452	0.000486	CcSEcCtD
Indapamide—Paraesthesia—Docetaxel—pancreatic cancer	0.000449	0.000483	CcSEcCtD
Indapamide—Erythema multiforme—Epirubicin—pancreatic cancer	0.000448	0.000483	CcSEcCtD
Indapamide—Vomiting—Gemcitabine—pancreatic cancer	0.000448	0.000482	CcSEcCtD
Indapamide—Dyspnoea—Docetaxel—pancreatic cancer	0.000445	0.000479	CcSEcCtD
Indapamide—Somnolence—Docetaxel—pancreatic cancer	0.000444	0.000478	CcSEcCtD
Indapamide—Rash—Gemcitabine—pancreatic cancer	0.000444	0.000478	CcSEcCtD
Indapamide—Dermatitis—Gemcitabine—pancreatic cancer	0.000443	0.000477	CcSEcCtD
Indapamide—Tinnitus—Epirubicin—pancreatic cancer	0.000442	0.000476	CcSEcCtD
Indapamide—Headache—Gemcitabine—pancreatic cancer	0.000441	0.000475	CcSEcCtD
Indapamide—Flushing—Epirubicin—pancreatic cancer	0.00044	0.000474	CcSEcCtD
Indapamide—Cardiac disorder—Epirubicin—pancreatic cancer	0.00044	0.000474	CcSEcCtD
Indapamide—Vomiting—Fluorouracil—pancreatic cancer	0.00044	0.000474	CcSEcCtD
Indapamide—Rhinitis—Doxorubicin—pancreatic cancer	0.00044	0.000473	CcSEcCtD
Indapamide—Dyspepsia—Docetaxel—pancreatic cancer	0.00044	0.000473	CcSEcCtD
Indapamide—Hepatitis—Doxorubicin—pancreatic cancer	0.000439	0.000472	CcSEcCtD
Indapamide—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000437	0.00047	CcSEcCtD
Indapamide—Rash—Fluorouracil—pancreatic cancer	0.000436	0.00047	CcSEcCtD
Indapamide—Dermatitis—Fluorouracil—pancreatic cancer	0.000436	0.000469	CcSEcCtD
Indapamide—Pharyngitis—Doxorubicin—pancreatic cancer	0.000436	0.000469	CcSEcCtD
Indapamide—Decreased appetite—Docetaxel—pancreatic cancer	0.000434	0.000467	CcSEcCtD
Indapamide—Headache—Fluorouracil—pancreatic cancer	0.000434	0.000467	CcSEcCtD
Indapamide—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000433	0.000466	CcSEcCtD
Indapamide—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000432	0.000465	CcSEcCtD
Indapamide—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000431	0.000464	CcSEcCtD
Indapamide—Fatigue—Docetaxel—pancreatic cancer	0.000431	0.000464	CcSEcCtD
Indapamide—Urethral disorder—Doxorubicin—pancreatic cancer	0.00043	0.000463	CcSEcCtD
Indapamide—Nausea—Irinotecan—pancreatic cancer	0.000429	0.000462	CcSEcCtD
Indapamide—Pain—Docetaxel—pancreatic cancer	0.000427	0.00046	CcSEcCtD
Indapamide—Constipation—Docetaxel—pancreatic cancer	0.000427	0.00046	CcSEcCtD
Indapamide—Arrhythmia—Epirubicin—pancreatic cancer	0.000424	0.000456	CcSEcCtD
Indapamide—Visual impairment—Doxorubicin—pancreatic cancer	0.000423	0.000455	CcSEcCtD
Indapamide—Nausea—Gemcitabine—pancreatic cancer	0.000418	0.00045	CcSEcCtD
Indapamide—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000415	0.000447	CcSEcCtD
Indapamide—Erythema—Epirubicin—pancreatic cancer	0.000413	0.000444	CcSEcCtD
Indapamide—Malnutrition—Epirubicin—pancreatic cancer	0.000413	0.000444	CcSEcCtD
Indapamide—Feeling abnormal—Docetaxel—pancreatic cancer	0.000412	0.000443	CcSEcCtD
Indapamide—Nausea—Fluorouracil—pancreatic cancer	0.000411	0.000442	CcSEcCtD
Indapamide—Tinnitus—Doxorubicin—pancreatic cancer	0.000409	0.00044	CcSEcCtD
Indapamide—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000409	0.00044	CcSEcCtD
Indapamide—Flushing—Doxorubicin—pancreatic cancer	0.000407	0.000438	CcSEcCtD
Indapamide—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000407	0.000438	CcSEcCtD
Indapamide—Flatulence—Epirubicin—pancreatic cancer	0.000407	0.000438	CcSEcCtD
Indapamide—Tension—Epirubicin—pancreatic cancer	0.000405	0.000436	CcSEcCtD
Indapamide—Dysgeusia—Epirubicin—pancreatic cancer	0.000404	0.000435	CcSEcCtD
Indapamide—Nervousness—Epirubicin—pancreatic cancer	0.000401	0.000432	CcSEcCtD
Indapamide—Back pain—Epirubicin—pancreatic cancer	0.000399	0.00043	CcSEcCtD
Indapamide—Muscle spasms—Epirubicin—pancreatic cancer	0.000397	0.000427	CcSEcCtD
Indapamide—Body temperature increased—Docetaxel—pancreatic cancer	0.000395	0.000425	CcSEcCtD
Indapamide—Abdominal pain—Docetaxel—pancreatic cancer	0.000395	0.000425	CcSEcCtD
Indapamide—Arrhythmia—Doxorubicin—pancreatic cancer	0.000392	0.000422	CcSEcCtD
Indapamide—Vision blurred—Epirubicin—pancreatic cancer	0.000389	0.000419	CcSEcCtD
Indapamide—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000383	0.000412	CcSEcCtD
Indapamide—Malnutrition—Doxorubicin—pancreatic cancer	0.000382	0.000411	CcSEcCtD
Indapamide—Erythema—Doxorubicin—pancreatic cancer	0.000382	0.000411	CcSEcCtD
Indapamide—Anaemia—Epirubicin—pancreatic cancer	0.000382	0.000411	CcSEcCtD
Indapamide—Agitation—Epirubicin—pancreatic cancer	0.000379	0.000408	CcSEcCtD
Indapamide—Flatulence—Doxorubicin—pancreatic cancer	0.000376	0.000405	CcSEcCtD
Indapamide—Tension—Doxorubicin—pancreatic cancer	0.000375	0.000403	CcSEcCtD
Indapamide—Dysgeusia—Doxorubicin—pancreatic cancer	0.000374	0.000403	CcSEcCtD
Indapamide—Malaise—Epirubicin—pancreatic cancer	0.000372	0.000401	CcSEcCtD
Indapamide—Nervousness—Doxorubicin—pancreatic cancer	0.000371	0.000399	CcSEcCtD
Indapamide—Vertigo—Epirubicin—pancreatic cancer	0.000371	0.000399	CcSEcCtD
Indapamide—Syncope—Epirubicin—pancreatic cancer	0.00037	0.000398	CcSEcCtD
Indapamide—Leukopenia—Epirubicin—pancreatic cancer	0.00037	0.000398	CcSEcCtD
Indapamide—Back pain—Doxorubicin—pancreatic cancer	0.00037	0.000398	CcSEcCtD
Indapamide—Hypersensitivity—Docetaxel—pancreatic cancer	0.000368	0.000396	CcSEcCtD
Indapamide—Muscle spasms—Doxorubicin—pancreatic cancer	0.000367	0.000395	CcSEcCtD
Indapamide—Palpitations—Epirubicin—pancreatic cancer	0.000365	0.000393	CcSEcCtD
Indapamide—Loss of consciousness—Epirubicin—pancreatic cancer	0.000363	0.000391	CcSEcCtD
Indapamide—Cough—Epirubicin—pancreatic cancer	0.00036	0.000388	CcSEcCtD
Indapamide—Vision blurred—Doxorubicin—pancreatic cancer	0.00036	0.000387	CcSEcCtD
Indapamide—Asthenia—Docetaxel—pancreatic cancer	0.000358	0.000386	CcSEcCtD
Indapamide—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000354	0.000381	CcSEcCtD
Indapamide—Pruritus—Docetaxel—pancreatic cancer	0.000353	0.00038	CcSEcCtD
Indapamide—Anaemia—Doxorubicin—pancreatic cancer	0.000353	0.00038	CcSEcCtD
Indapamide—Chest pain—Epirubicin—pancreatic cancer	0.000352	0.000378	CcSEcCtD
Indapamide—Arthralgia—Epirubicin—pancreatic cancer	0.000352	0.000378	CcSEcCtD
Indapamide—Myalgia—Epirubicin—pancreatic cancer	0.000352	0.000378	CcSEcCtD
Indapamide—Agitation—Doxorubicin—pancreatic cancer	0.000351	0.000378	CcSEcCtD
Indapamide—Anxiety—Epirubicin—pancreatic cancer	0.00035	0.000377	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000349	0.000376	CcSEcCtD
Indapamide—Discomfort—Epirubicin—pancreatic cancer	0.000347	0.000374	CcSEcCtD
Indapamide—Malaise—Doxorubicin—pancreatic cancer	0.000345	0.000371	CcSEcCtD
Indapamide—Dry mouth—Epirubicin—pancreatic cancer	0.000344	0.00037	CcSEcCtD
Indapamide—Vertigo—Doxorubicin—pancreatic cancer	0.000343	0.000369	CcSEcCtD
Indapamide—Syncope—Doxorubicin—pancreatic cancer	0.000343	0.000369	CcSEcCtD
Indapamide—Leukopenia—Doxorubicin—pancreatic cancer	0.000342	0.000368	CcSEcCtD
Indapamide—Diarrhoea—Docetaxel—pancreatic cancer	0.000342	0.000368	CcSEcCtD
Indapamide—Palpitations—Doxorubicin—pancreatic cancer	0.000338	0.000363	CcSEcCtD
Indapamide—Oedema—Epirubicin—pancreatic cancer	0.000337	0.000363	CcSEcCtD
Indapamide—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000337	0.000363	CcSEcCtD
Indapamide—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000336	0.000361	CcSEcCtD
Indapamide—Infection—Epirubicin—pancreatic cancer	0.000335	0.00036	CcSEcCtD
Indapamide—Cough—Doxorubicin—pancreatic cancer	0.000333	0.000359	CcSEcCtD
Indapamide—Shock—Epirubicin—pancreatic cancer	0.000332	0.000357	CcSEcCtD
Indapamide—Nervous system disorder—Epirubicin—pancreatic cancer	0.00033	0.000356	CcSEcCtD
Indapamide—Dizziness—Docetaxel—pancreatic cancer	0.00033	0.000356	CcSEcCtD
Indapamide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.00033	0.000355	CcSEcCtD
Indapamide—Tachycardia—Epirubicin—pancreatic cancer	0.000329	0.000354	CcSEcCtD
Indapamide—Skin disorder—Epirubicin—pancreatic cancer	0.000327	0.000352	CcSEcCtD
Indapamide—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000326	0.000351	CcSEcCtD
Indapamide—Chest pain—Doxorubicin—pancreatic cancer	0.000325	0.00035	CcSEcCtD
Indapamide—Arthralgia—Doxorubicin—pancreatic cancer	0.000325	0.00035	CcSEcCtD
Indapamide—Myalgia—Doxorubicin—pancreatic cancer	0.000325	0.00035	CcSEcCtD
Indapamide—Anxiety—Doxorubicin—pancreatic cancer	0.000324	0.000349	CcSEcCtD
Indapamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000323	0.000348	CcSEcCtD
Indapamide—Discomfort—Doxorubicin—pancreatic cancer	0.000321	0.000346	CcSEcCtD
Indapamide—Anorexia—Epirubicin—pancreatic cancer	0.000321	0.000346	CcSEcCtD
Indapamide—Dry mouth—Doxorubicin—pancreatic cancer	0.000318	0.000342	CcSEcCtD
Indapamide—Vomiting—Docetaxel—pancreatic cancer	0.000318	0.000342	CcSEcCtD
Indapamide—Rash—Docetaxel—pancreatic cancer	0.000315	0.000339	CcSEcCtD
Indapamide—Hypotension—Epirubicin—pancreatic cancer	0.000315	0.000339	CcSEcCtD
Indapamide—Dermatitis—Docetaxel—pancreatic cancer	0.000315	0.000339	CcSEcCtD
Indapamide—Headache—Docetaxel—pancreatic cancer	0.000313	0.000337	CcSEcCtD
Indapamide—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000312	0.000336	CcSEcCtD
Indapamide—Oedema—Doxorubicin—pancreatic cancer	0.000312	0.000336	CcSEcCtD
Indapamide—Infection—Doxorubicin—pancreatic cancer	0.00031	0.000333	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000307	0.00033	CcSEcCtD
Indapamide—Shock—Doxorubicin—pancreatic cancer	0.000307	0.00033	CcSEcCtD
Indapamide—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000306	0.000329	CcSEcCtD
Indapamide—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000305	0.000329	CcSEcCtD
Indapamide—Insomnia—Epirubicin—pancreatic cancer	0.000305	0.000328	CcSEcCtD
Indapamide—Tachycardia—Doxorubicin—pancreatic cancer	0.000304	0.000327	CcSEcCtD
Indapamide—Skin disorder—Doxorubicin—pancreatic cancer	0.000303	0.000326	CcSEcCtD
Indapamide—Paraesthesia—Epirubicin—pancreatic cancer	0.000303	0.000326	CcSEcCtD
Indapamide—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000301	0.000324	CcSEcCtD
Indapamide—Dyspnoea—Epirubicin—pancreatic cancer	0.0003	0.000323	CcSEcCtD
Indapamide—Somnolence—Epirubicin—pancreatic cancer	0.0003	0.000322	CcSEcCtD
Indapamide—Anorexia—Doxorubicin—pancreatic cancer	0.000297	0.00032	CcSEcCtD
Indapamide—Nausea—Docetaxel—pancreatic cancer	0.000297	0.000319	CcSEcCtD
Indapamide—Dyspepsia—Epirubicin—pancreatic cancer	0.000297	0.000319	CcSEcCtD
Indapamide—Decreased appetite—Epirubicin—pancreatic cancer	0.000293	0.000315	CcSEcCtD
Indapamide—Hypotension—Doxorubicin—pancreatic cancer	0.000291	0.000314	CcSEcCtD
Indapamide—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000291	0.000313	CcSEcCtD
Indapamide—Fatigue—Epirubicin—pancreatic cancer	0.000291	0.000313	CcSEcCtD
Indapamide—Constipation—Epirubicin—pancreatic cancer	0.000288	0.00031	CcSEcCtD
Indapamide—Pain—Epirubicin—pancreatic cancer	0.000288	0.00031	CcSEcCtD
Indapamide—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000284	0.000306	CcSEcCtD
Indapamide—Insomnia—Doxorubicin—pancreatic cancer	0.000282	0.000303	CcSEcCtD
Indapamide—Paraesthesia—Doxorubicin—pancreatic cancer	0.00028	0.000301	CcSEcCtD
Indapamide—Dyspnoea—Doxorubicin—pancreatic cancer	0.000278	0.000299	CcSEcCtD
Indapamide—Feeling abnormal—Epirubicin—pancreatic cancer	0.000278	0.000299	CcSEcCtD
Indapamide—Somnolence—Doxorubicin—pancreatic cancer	0.000277	0.000298	CcSEcCtD
Indapamide—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000276	0.000297	CcSEcCtD
Indapamide—Dyspepsia—Doxorubicin—pancreatic cancer	0.000274	0.000295	CcSEcCtD
Indapamide—Decreased appetite—Doxorubicin—pancreatic cancer	0.000271	0.000292	CcSEcCtD
Indapamide—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000269	0.00029	CcSEcCtD
Indapamide—Fatigue—Doxorubicin—pancreatic cancer	0.000269	0.000289	CcSEcCtD
Indapamide—Urticaria—Epirubicin—pancreatic cancer	0.000268	0.000288	CcSEcCtD
Indapamide—Pain—Doxorubicin—pancreatic cancer	0.000267	0.000287	CcSEcCtD
Indapamide—Constipation—Doxorubicin—pancreatic cancer	0.000267	0.000287	CcSEcCtD
Indapamide—Abdominal pain—Epirubicin—pancreatic cancer	0.000266	0.000287	CcSEcCtD
Indapamide—Body temperature increased—Epirubicin—pancreatic cancer	0.000266	0.000287	CcSEcCtD
Indapamide—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000257	0.000277	CcSEcCtD
Indapamide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000255	0.000274	CcSEcCtD
Indapamide—Hypersensitivity—Epirubicin—pancreatic cancer	0.000248	0.000267	CcSEcCtD
Indapamide—Urticaria—Doxorubicin—pancreatic cancer	0.000248	0.000267	CcSEcCtD
Indapamide—Abdominal pain—Doxorubicin—pancreatic cancer	0.000246	0.000265	CcSEcCtD
Indapamide—Body temperature increased—Doxorubicin—pancreatic cancer	0.000246	0.000265	CcSEcCtD
Indapamide—Asthenia—Epirubicin—pancreatic cancer	0.000242	0.00026	CcSEcCtD
Indapamide—Pruritus—Epirubicin—pancreatic cancer	0.000238	0.000257	CcSEcCtD
Indapamide—Diarrhoea—Epirubicin—pancreatic cancer	0.000231	0.000248	CcSEcCtD
Indapamide—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00023	0.000247	CcSEcCtD
Indapamide—Asthenia—Doxorubicin—pancreatic cancer	0.000224	0.000241	CcSEcCtD
Indapamide—Dizziness—Epirubicin—pancreatic cancer	0.000223	0.00024	CcSEcCtD
Indapamide—Pruritus—Doxorubicin—pancreatic cancer	0.000221	0.000237	CcSEcCtD
Indapamide—Vomiting—Epirubicin—pancreatic cancer	0.000214	0.000231	CcSEcCtD
Indapamide—Diarrhoea—Doxorubicin—pancreatic cancer	0.000213	0.00023	CcSEcCtD
Indapamide—Rash—Epirubicin—pancreatic cancer	0.000212	0.000229	CcSEcCtD
Indapamide—Dermatitis—Epirubicin—pancreatic cancer	0.000212	0.000228	CcSEcCtD
Indapamide—Headache—Epirubicin—pancreatic cancer	0.000211	0.000227	CcSEcCtD
Indapamide—Dizziness—Doxorubicin—pancreatic cancer	0.000206	0.000222	CcSEcCtD
Indapamide—Nausea—Epirubicin—pancreatic cancer	0.0002	0.000215	CcSEcCtD
Indapamide—Vomiting—Doxorubicin—pancreatic cancer	0.000198	0.000213	CcSEcCtD
Indapamide—Rash—Doxorubicin—pancreatic cancer	0.000197	0.000212	CcSEcCtD
Indapamide—Dermatitis—Doxorubicin—pancreatic cancer	0.000196	0.000211	CcSEcCtD
Indapamide—Headache—Doxorubicin—pancreatic cancer	0.000195	0.00021	CcSEcCtD
Indapamide—Nausea—Doxorubicin—pancreatic cancer	0.000185	0.000199	CcSEcCtD
